Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/28793
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2022-09-16T12:18:50Z | - |
dc.date.available | 2022-09-16T12:18:50Z | - |
dc.date.issued | 2007-04 | - |
dc.identifier.citation | Ali, R. vd. (2007). "Tumour lysis syndrome with acute renal failure during imatinib therapy". Leukemia Research, 31(4), 573-574. | en_US |
dc.identifier.issn | 0145-2126 | - |
dc.identifier.issn | 1873-5835 | - |
dc.identifier.uri | https://doi.org/10.1016/j.leukres.2006.05.005 | - |
dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S0145212606001639 | - |
dc.identifier.uri | http://hdl.handle.net/11452/28793 | - |
dc.language.iso | en | en_US |
dc.publisher | Pergamon-Elsevier Science | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Acute renal failure | en_US |
dc.subject | Cancer | en_US |
dc.subject | Imatinib | en_US |
dc.subject | Leukemia | en_US |
dc.subject | Tumour lysis syndrome | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Antineoplastic agents | en_US |
dc.subject.mesh | Kidney neoplasms | en_US |
dc.subject.mesh | Middle Aged | en_US |
dc.subject.mesh | Leukemia, myeloid, chronic | en_US |
dc.subject.mesh | Kidney failure, acute | en_US |
dc.subject.mesh | Leukemia, myeloid, philadelphia-positive | en_US |
dc.subject.mesh | Piperazines | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Protein-tyrosine kinases | en_US |
dc.subject.mesh | Pyrimidines | en_US |
dc.subject.mesh | Tumor lysis syndrome | en_US |
dc.title | Tumour lysis syndrome with acute renal failure during imatinib therapy | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000244826600025 | tr_TR |
dc.identifier.scopus | 2-s2.0-33846702520 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Hematoloji Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Nefroloji Anabilim Dalı. | tr_TR |
dc.identifier.startpage | 573 | tr_TR |
dc.identifier.endpage | 574 | tr_TR |
dc.identifier.volume | 31 | tr_TR |
dc.identifier.issue | 4 | tr_TR |
dc.relation.journal | Leukemia Research | en_US |
dc.contributor.buuauthor | Ali, Rıdvan | - |
dc.contributor.buuauthor | Özkalemkaş, Fahir | - |
dc.contributor.buuauthor | Özkan, Atilla | - |
dc.contributor.buuauthor | Özçelik, Tülay | - |
dc.contributor.buuauthor | Özkocaman, Vildan | - |
dc.contributor.buuauthor | Akdağ, İbrahim | - |
dc.contributor.buuauthor | Ozan, Ülkü | - |
dc.contributor.researcherid | AAG-8495-2021 | tr_TR |
dc.contributor.researcherid | AAH-1854-2021 | tr_TR |
dc.identifier.pubmed | 16782190 | tr_TR |
dc.subject.wos | Oncology | en_US |
dc.subject.wos | Hematology | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.wos.quartile | Q2 (Hematology) | en_US |
dc.wos.quartile | Q3 (Oncology) | en_US |
dc.contributor.scopusid | 7201813027 | tr_TR |
dc.contributor.scopusid | 6601912387 | tr_TR |
dc.contributor.scopusid | 9250698600 | tr_TR |
dc.contributor.scopusid | 7005424333 | tr_TR |
dc.contributor.scopusid | 6603145040 | tr_TR |
dc.contributor.scopusid | 8342488100 | tr_TR |
dc.contributor.scopusid | 6507254632 | tr_TR |
dc.contributor.scopusid | 6602797853 | tr_TR |
dc.subject.scopus | Tumor Lysis Syndrome; Rasburicase; Hyperphosphatemia | en_US |
dc.subject.emtree | Furosemide | en_US |
dc.subject.emtree | Allopurinol | en_US |
dc.subject.emtree | Asparaginase | en_US |
dc.subject.emtree | Calcium | en_US |
dc.subject.emtree | Creatinine | en_US |
dc.subject.emtree | Cyclophosphamide | en_US |
dc.subject.emtree | Daunorubicin | en_US |
dc.subject.emtree | Diuretic agent | en_US |
dc.subject.emtree | Imatinib | en_US |
dc.subject.emtree | Rare disease | en_US |
dc.subject.emtree | Hemoglobin | en_US |
dc.subject.emtree | Hydroxyurea | en_US |
dc.subject.emtree | Phosphorus | en_US |
dc.subject.emtree | Priority journal | en_US |
dc.subject.emtree | Tumor lysis syndrome | en_US |
dc.subject.emtree | Prednisolone | en_US |
dc.subject.emtree | Urea | en_US |
dc.subject.emtree | Uric acid | en_US |
dc.subject.emtree | Vincristine | en_US |
dc.subject.emtree | Acute kidney failure | en_US |
dc.subject.emtree | Potassium | en_US |
dc.subject.emtree | Adult | en_US |
dc.subject.emtree | Cancer combination chemotherapy | en_US |
dc.subject.emtree | Fatigue | en_US |
dc.subject.emtree | Case report | en_US |
dc.subject.emtree | Chronic myeloid leukemia | en_US |
dc.subject.emtree | Dehydration | en_US |
dc.subject.emtree | Drug effect | en_US |
dc.subject.emtree | Drug withdrawal | en_US |
dc.subject.emtree | Dyspnea | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Letter | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Pallor | en_US |
dc.subject.emtree | Petechia | en_US |
dc.subject.emtree | Purpura | en_US |
dc.subject.emtree | Retreatment | en_US |
dc.subject.emtree | Treatment outcome | en_US |
Appears in Collections: | PubMed Scopus Web of Science |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.